PIONEER BRADGATE
PIONEER BRADGATE
Embedded Files
Information correct as of: April 2024
1) Are there transgender Shared Care Agreement and Bridging Prescription policy/guidance documents in use at your practice?
1) Are there transgender Shared Care Agreement and Bridging Prescription policy/guidance documents in use at your practice?
No response.
2) How many transgender Shared Care Agreements do you currently have in place?
2) How many transgender Shared Care Agreements do you currently have in place?
No response.
3) When presented with a transgender patient that is self-medicating, does your service offer to monitor bloods without a Shared Care Agreement or Bridging Prescription in place? If so, what blood tests are included for those taking feminising HRT and those taking masculinising HRT?
3) When presented with a transgender patient that is self-medicating, does your service offer to monitor bloods without a Shared Care Agreement or Bridging Prescription in place? If so, what blood tests are included for those taking feminising HRT and those taking masculinising HRT?
No response.
4) When a Bridging Prescription is provided, what blood tests are included for those taking feminising HRT and those taking masculinising HRT?
4) When a Bridging Prescription is provided, what blood tests are included for those taking feminising HRT and those taking masculinising HRT?
No response.
5) Bridging Prescriptions are considered a "harm reduction strategy" in transgender healthcare (Royal College of Psychiatrists (October 2013) CR181: Good Practice Guidelines for the Assessment and Treatment of Adults with Gender Dysphoria).
5) Bridging Prescriptions are considered a "harm reduction strategy" in transgender healthcare (Royal College of Psychiatrists (October 2013) CR181: Good Practice Guidelines for the Assessment and Treatment of Adults with Gender Dysphoria).
Does your practice advise GPs to undertake a patient safety risk assessment before issuing, rejecting or ending a Bridging Prescription?
Does your practice advise GPs to undertake a patient safety risk assessment before issuing, rejecting or ending a Bridging Prescription?
No response.
6) The GMC recommends that GPs should collaborate with gender specialists in the provision of transgender healthcare; if the GP cannot access a gender specialist the GMC states "it would not (however), be acceptable to simply refuse to treat the patient" (LINK).
6) The GMC recommends that GPs should collaborate with gender specialists in the provision of transgender healthcare; if the GP cannot access a gender specialist the GMC states "it would not (however), be acceptable to simply refuse to treat the patient" (LINK).
If a GP at your practice cannot access the advice of a gender specialist, what is the protocol they will follow?
If a GP at your practice cannot access the advice of a gender specialist, what is the protocol they will follow?
No response.
COMMUNITY NOTES
COMMUNITY NOTES
Page updated
Google Sites
Report abuse